Newsletter | February 16, 2024

02.16.24 -- Using AI For Rare Disease Drug Development


Unlocking The Truth Behind Large CROs: Exposing The Great Talent Misconception

Large CROs have a vast pool of resources and a subset of amazingly talented people. However, the decision to select such a CRO on the concept that they have access to the best talent, and the hope that those resources will be assigned to your study, is flawed. Discover ways to overcome those faults by creating a culture where excellence, grit, and patient-centricity thrive.


How AI Is Helping Drug Developers Help Rare Disease Patients

BioCryst's chief R&D officer provides examples of how AI and machine learning tools are being used to improve rare disease drug discovery and development.

The Ozempic Dilemma: What Makes A Dual Brand Approach Viable?

When should a brand become two brands? Charles River Associates provide analyses and case studies of dual brands to elucidate the pros and cons.


Unlocking Scalability In Pharma With AI

Uncover how artificial intelligence and machine learning could emerge as the most pivotal technologies of our era, with the potential to facilitate scalability in pharmaceuticals and other industries.

A Big Difference In Supply Chain Management Using Little’s Law

Explore how leveraging Little’s Law to quantify metrics that otherwise would be causing confusion and process interruption can help to reduce wait times and deliver materials on time and within budget.

Partnering On An Innovative Hydrogel-Based Treatment For Glioblastoma

Treatments for glioblastoma multiforme (GBM) are in high demand. Learn more about the new possibilities for increased dosing and diffusion capabilities offered by nanoformed APIs.

Making The Case For Case Management Of Cell And Gene Therapies

It is crucial to ensure that cell and gene therapy supply chain risks are mitigated and to have proactive strategies in place to address unforeseen challenges before they become an issue.


Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: